320 related articles for article (PubMed ID: 38675906)
1. Deciphering the Role of Epstein-Barr Virus Latent Membrane Protein 1 in Immune Modulation: A Multifaced Signalling Perspective.
Šimičić P; Batović M; Stojanović Marković A; Židovec-Lepej S
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675906
[TBL] [Abstract][Full Text] [Related]
2. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
3. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
4. The Latent Membrane Protein 1 (LMP1).
Kieser A; Sterz KR
Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
[TBL] [Abstract][Full Text] [Related]
5. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
[TBL] [Abstract][Full Text] [Related]
6. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
[TBL] [Abstract][Full Text] [Related]
8. Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.
Middeldorp JM; Pegtel DM
Semin Cancer Biol; 2008 Dec; 18(6):388-96. PubMed ID: 19013244
[TBL] [Abstract][Full Text] [Related]
9. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.
Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J
Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.
Ndour PA; Brocqueville G; Ouk TS; Goormachtigh G; Morales O; Mougel A; Bertout J; Melnyk O; Fafeur V; Feuillard J; Coll J; Adriaenssens E
J Virol; 2012 Apr; 86(7):3934-43. PubMed ID: 22258264
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
12. Role of LMP1 in immune control of EBV infection.
Pai S; Khanna R
Semin Cancer Biol; 2001 Dec; 11(6):455-60. PubMed ID: 11669607
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
[TBL] [Abstract][Full Text] [Related]
14. NF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.
Ersing I; Bernhardt K; Gewurz BE
Viruses; 2013 Jun; 5(6):1587-606. PubMed ID: 23793113
[TBL] [Abstract][Full Text] [Related]
15. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.
Pang MF; Lin KW; Peh SC
Cell Mol Biol Lett; 2009; 14(2):222-47. PubMed ID: 19082921
[TBL] [Abstract][Full Text] [Related]
16. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus.
Bouvet M; Voigt S; Tagawa T; Albanese M; Chen YA; Chen Y; Fachko DN; Pich D; Göbel C; Skalsky RL; Hammerschmidt W
mBio; 2021 Mar; 12(2):. PubMed ID: 33785626
[TBL] [Abstract][Full Text] [Related]
17. Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.
DeKroon RM; Gunawardena HP; Edwards R; Raab-Traub N
mBio; 2018 Jun; 9(3):. PubMed ID: 29921667
[TBL] [Abstract][Full Text] [Related]
18. [Molecular biological properties of the Epstein-Barr virus LMP1 gene: structure, function and polymorphism].
Smirnova KV; Diduk SV; Senyuta NB; Gurtsevitch VE
Vopr Virusol; 2015; 60(3):5-13. PubMed ID: 26281300
[TBL] [Abstract][Full Text] [Related]
19. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
[TBL] [Abstract][Full Text] [Related]
20. Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kappaB and JNK signaling pathways.
Goormachtigh G; Ouk TS; Mougel A; Tranchand-Bunel D; Masy E; Le Clorennec C; Feuillard J; Bornkamm GW; Auriault C; Manet E; Fafeur V; Adriaenssens E; Coll J
J Virol; 2006 Aug; 80(15):7382-93. PubMed ID: 16840319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
